Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck

Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In particular, the EXTREME study has indicated cetuximab as the only drug to improve survival when associated with cisplatin a...

Descripción completa

Detalles Bibliográficos
Autores principales: Perri, Francesco, Longo, Francesco, Ionna, Franco, Caponigro, Francesco
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886337/
https://www.ncbi.nlm.nih.gov/pubmed/20616911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886337/
https://www.ncbi.nlm.nih.gov/pubmed/20616911

Ejemplares similares